￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Recommendations for the use of tilpotide/tirsiparatide (Mufenda) in special populations

2026-02-01 22:25:32

Check Details
Pitobrutinib/Pitobrutinib (Zepali) generally requires several courses of treatment to be effective

2026-02-01 22:25:32

Check Details
The best daily taking time and medication precautions for Talazoparib (Tazena)

2026-02-01 22:25:32

Check Details
Analysis of treatment methods and protocols after emergence of resistance to crizotinib (Xalkori)

2026-02-01 22:25:32

Check Details
Guanfacine extended-release tablets (Guanfacine) common side effects, safety monitoring and long-term medication risk analysis

2026-02-01 22:25:32

Check Details
Pacritinib (pacritinib) India price, formal import channels and clinical use reference analysis

2026-02-01 22:25:32

Check Details
Analysis of the scope of indications and clinical application of Letermovir (Premin)

2026-02-01 22:25:32

Check Details
Etrasimod tablets (Etrasimod)-Velsipity clinical efficacy performance, patient feedback and use experience analysis

2026-02-01 22:25:32

Check Details
Analysis of the pharmacological effects, indications and clinical application value of Rutrombopag Tablets (Wenda)

2026-02-01 22:25:32

Check Details
Important points to note when using Omarigliptin, contraindication groups and safe medication risk analysis

2026-02-01 22:25:32

Check Details
Analysis of lecanemab-LEQEMBI manufacturer’s research and development status and regular sales channels

2026-02-01 22:25:32

Check Details
Golodirsen research and development background and analysis of overseas drug purchase channels

2026-02-01 22:25:32

Check Details
Category
相关知识